scorecardresearch
Business Today
Subscribe
Immersives UPSTART G20 Summit Corporate Petrol-Diesel Weather BT Bazaar
BT 100 BT Accenture PwC De-risking the Future BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
News
Markets
Stocks
Bacil Pharma Ltd

Feedback
Bacil Pharma Ltd

Bacil Pharma Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 300
Sep 14, 2023 16:01 IST-
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹6.17
₹0.25 (-3.89%)
    Powered By :
₹6.11 Low
Today’s Performance
₹6.17 High
₹4.05 Low
52 Week’s Performance
₹9.82 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -3.89%
  • 1 Week -15.94%
  • 1 Month -32.05%
  • 3 Months -33.80%
  • 6 Months -1.59%
  • 1 Year 38.03%
  • 3 Years 23.95%
  • 5 Years 10.18%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.84
  • 52-Week Low (₹) 4.05
  • 52-Week High (₹) 9.82
  • Price-to-Book (X)* 7.86
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 0.00
  • Earnings Per Share (₹) 0.00
  • Sector Price Earning (X)* 33.20
  • Market Cap (₹ Cr.)* 3.63
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 39:53 Historic India-Middle East-Europe Corridor Puts China On Notice
THUMB 5:05 Delhi Tops In Terms Of Electric Buses After Arvind Kejriwal Govt Introduces 400 New Buses
thumb 4:42 The India-Middle East-Europe Corridor: A Counter To China's Belt & Road Initiative
THUMB 4:04 Putin Praises Modi’s ‘Make In India’, Cites Example To Russian Auto Industry
THUMB 9:44 Tata Motors' Electrifying Future: In Conversation With Shailesh Chandra On EV Expansion
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Mar 26, 2021 Sell
BACPHAR ,KHEM SUM APPARELS OVERSEAS LTD
  • Qty 270000
  • Average Price ₹3.10
Mar 26, 2021 PURCHASE
BACPHAR ,PRAKASH SHAH
  • Qty 270780
  • Average Price ₹3.10
Mar 30, 2021 PURCHASE
BACPHAR ,PARIKSHIT K NOTARIA
  • Qty 140000
  • Average Price ₹3.11
Mar 30, 2021 Sell
BACPHAR ,KHEM SUM APPARELS OVERSEAS LTD
  • Qty 143800
  • Average Price ₹3.11
Aug 23, 2019 PURCHASE
BACPHAR ,PRAKASH SHAH
  • Qty 43250
  • Average Price ₹2.07
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Bacil Pharma Ltd share price previously?
Bacil Pharma Ltd share price was down by -3.89% from the previous closing price of ₹6.42.
Who are peers of Bacil Pharma Ltd?
The peers of Bacil Pharma Ltd are Glenmark Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd, Biocon Ltd, Torrent Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Glaxosmithkline Pharmaceuticals Ltd, Gland Pharma Ltd, Lupin Ltd, Divis Laboratories Ltd, Syngene International Ltd.
Who is/are the promoter/promoters of Bacil Pharma Ltd?
The promotor/promotors of Bacil Pharma Ltd are Prakash Shah, Ganpat Dhondu Salekar, Shirish Shetye, Parul Dave, Suman Shah.
What has been 52-week high of Bacil Pharma Ltd stocks?
The highest price of Bacil Pharma Ltd stock is ₹9.82 in the last 52-week.
What is the share price of Bacil Pharma Ltd () today on BSE?
As on Sep 14, 2023, Bacil Pharma Ltd ()’s share price on BSE is Rs 6.17
What is the market cap of Bacil Pharma Ltd (?)
The current market capitalisation of Bacil Pharma Ltd () is 3.63 crores
What is Bacil Pharma Ltd Share symbol?
The symbol of Bacil Pharma Ltd is .
What is the PE ratio of Bacil Pharma Ltd ()?
The current PE ratio of Bacil Pharma Ltd () is 0.00.
What is the PB ratio of Bacil Pharma Ltd ()?
The current PB ratio of Bacil Pharma Ltd () is 7.86.
Today’s High & Low share prices of Bacil Pharma Ltd () on BSE?
Today, the share price of Bacil Pharma Ltd () on BSE touched a high of Rs 6.17 and a low of Rs 6.11
What price did Bacil Pharma Ltd () shares open on the BSE today?
On BSE, the share price of Bacil Pharma Ltd () opened at Rs 6.11
What is the 52-week high of Bacil Pharma Ltd ()?
The 52-week high price of Bacil Pharma Ltd () is Rs 9.82
What is the 52-week low of Bacil Pharma Ltd () ?
The 52-week low price of Bacil Pharma Ltd () is Rs 4.05

ABOUT BACIL PHARMA

Bacil Pharma Ltd, incorporated in the year 1987, has its registered office in 71 Laxmi Building, Sir P M Road Fort, Mumbai, Maharashtra, 400001, 91-022-22618452, 91-022-22009603. The main industry in which Bacil Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Bacil Pharma Ltd is/are Laxmikant Kabra & Co LLP. In the main management, is chairman and is the company secretary for Bacil Pharma Ltd.

  • PS Prakash Shah Director
  • GDS Ganpat Dhondu Salekar Director
  • SS Shirish Shetye Independent Director
  • PD Parul Dave Independent Director
  • SS Suman Shah Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.